The vascular stents market is experiencing significant growth, driven in large part by the increasing adoption of minimally invasive procedures like vascular angioplasty and stenting. Traditional surgical approaches to treat narrowed or blocked blood vessels often involve bypass grafts or more invasive techniques. Vascular angioplasty and stenting, on the other hand, offer a less-invasive alternative. This procedure involves inserting a catheter into the blocked vessel and inflating a tiny balloon to widen the opening. In many cases, a stent, a small expandable metal tube, is then placed within the vessel to help maintain its patency and prevent future narrowing. This minimally invasive approach is associated with faster recovery times, reduced patient discomfort, and potentially improved long-term outcomes for patients suffering from peripheral artery disease (PAD) and other vascular conditions.
The Vascular Stents Market is expected to reach USD 25.3 billion by 2030 at CAGR 7.40% CAGR during the forecast period of 2022-2030.
Vascular stents are crucial medical devices used to alleviate blockages in blood vessels or arteries, particularly in the treatment of coronary diseases. These tiny tube-like devices widen narrow vessels, reducing the risk of heart attacks and chest pain. The market for vascular stents is driven by the increasing prevalence of cardiovascular diseases, coupled with a global rise in obesity rates, where 39% of adults aged 18 years and over are overweight and 13% are obese.
Technological advancements and the growing obese population contribute to market growth. Additionally, benefits such as low infection risk and short recovery times propel market expansion. However, challenges such as the availability of alternative therapies and the high cost of ventricular stents may hinder market growth.
Companies are investing in research and development to enhance vascular stent products, with a focus on developing biodegradable stents to address existing drawbacks. Some major players adopt strategies like acquisitions and strategic alliances to drive market growth.
Key Players:
- Abbott Laboratories:A leading healthcare company headquartered in the US.
- Medtronic:The world's largest standalone medical technology development company, headquartered in the UK. Known for developing innovative products like the Stent Graft System for Endovascular Repair of Thoracoabdominal Aortic Aneurysms and the Resolute Drug-Eluting Stent.
- Cook Medical:A US-based medical device manufacturer known for products like Approach, Bird's Nest, and Advance.
Regional Analysis:
- North America:Commands the largest market share for vascular stents, driven by the increasing obese population, prevalence of cardiovascular diseases, and sedentary lifestyles.
- Europe:The second largest market for vascular stents, benefiting from advancements in technology and a significant patient population with vascular diseases.
- Asia Pacific:The fastest-growing market due to rapid technological development and a large patient base suffering from various vascular diseases.
- Middle East and Africa:Has the lowest market share due to limited development in the medical field.
Another factor contributing to the growth of the vascular stents market is the development of innovative technologies in angioplasty and vascular stenting. These advancements include the creation of drug-eluting stents, which are coated with medication to help prevent restenosis, the re-narrowing of the treated vessel. Biodegradable stents, which dissolve over time, are another area of active research and development. These advancements offer healthcare professionals a wider range of treatment options to tailor care to the specific needs of each patient. The ability to perform these procedures via minimally invasive techniques with advanced stents allows for improved patient outcomes and potentially reduces healthcare costs associated with more traditional surgical interventions.
Global Vascular Stents Market - Competitive Analysis
Boston Scientific Corporation (US), Abbott Laboratories (US), Medtronic, Plc (UK), Cook Medical (US), Biotronik se co. kg (Germany), B. Braun Melsungen AG (Germany), Cordis (US), Lombard Medical Technologies (UK), Translumina GmbH (Germany), MicroPort Scientific Corporation (China), Terumo Corporation (Japan), Vascular Concepts (India), W.L. Gore Associates (US), Meril Life Sciences Pvt. Ltd. (India) are some of the prominent Vascular Stents companies at the forefront of competition in the Global industry and are profiled in MRFR Analysis.
For more information visit at MarketResearchFuture
Other Trending Reports
